PharmaCorp Rx Inc.
PCRX.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 77.80K | -654.00K | -310.40K | -286.50K | 168.60K |
| Total Depreciation and Amortization | 253.40K | 245.20K | 161.40K | 136.30K | 130.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.20K | 183.70K | 142.30K | -7.00K | -5.50K |
| Change in Net Operating Assets | -2.30M | 1.31M | 406.10K | 22.10K | -203.40K |
| Cash from Operations | -1.92M | 1.09M | 399.50K | -135.00K | 90.30K |
| Capital Expenditure | -61.40K | -13.90K | 1.51M | -1.53M | -18.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -962.60K | -7.44M | -736.50K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.70K | -730.90K | -- | -- | -- |
| Cash from Investing | -74.10K | -1.71M | -5.93M | -2.27M | -18.70K |
| Total Debt Issued | -- | 3.16M | -- | -- | -- |
| Total Debt Repaid | -106.50K | -160.80K | -61.00K | -50.50K | -50.70K |
| Issuance of Common Stock | -- | 18.28M | 3.16M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 374.50K | 450.00K | -18.20K | -- | -- |
| Cash from Financing | 192.70K | 15.59M | 2.24M | -36.50K | -35.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.80M | 14.96M | -3.30M | -2.44M | 36.20K |